Oral Hypoglycemic Agent
“DEVELOPMENT AND CHARACTERIZATION OF NANOSTRUCTURED LIPID CARRIERS OF ORAL HYPOGLYCEMIC AGENT: SELECTION OF SURFACTANTS” by Nitin Kumar Jain*, Alpana Ram, India.
... an oral hypoglycemic agent, which is a most commonly used drug for the treatment of type II diabetes ...The oral absorption of Glipizide is uniform, rapid and complete with a bioavailability ...
6
Synthesis, Physico-Chemical and Antidiabetic Studies of Zinc Complex of Glimepiride, an Oral Hypoglycemic Agent
... To confir m the ligand metal ratio, conductometric titrations using monovariation method were carried out at 27±1 0 C 0.005M solution of glimepiride drug was prepared in 80:20[r] ...
8
Efficacy and safety of vildagliptin, sitagliptin, and linagliptin as add-on therapy in Chinese patients with T2DM inadequately controlled with dual combination of insulin and traditional oral hypoglycemic agent
... T2DM is a progressive disease that often requires a combination of antidiabetic drugs with different mecha- nisms of action to achieve glycemic targets over time [7]. Dipeptidyl peptidase 4 (DPP-4) inhibitors have become ...
9
SYNTHESIS, PHYSICO-CHEMICAL AND ANTIDIABETIC STUDIES OF ZINC COMPLEX OF GLIMEPIRIDE, AN ORAL HYPOGLYCEMIC AGENT
... more hypoglycemic activity. The hypoglycemic effect of glimepiride as well as metal complex were investigated on the blood sugar levels of male wistar rats by alloxan induced antidiabetic test (Seshadri ...
17
ORAL HYPOGLYCEMIC AGENT OVERVIEW
... Sulfonylureas, derived from sulfonic acid and urea, were initially developed in the 1950's and have remained a cornerstone of therapy for type 2 diabetes. The combination of their proven efficacy in most patients, low ...
27
Patterns of Adherence to Oral Hypoglycemic Agents: Patterns, Correlates, and Outcomes
... The CONSORT flow diagram for this trial has been published elsewhere (Bogner et al., 2012). In brief, of 715 patients with type 2 DM were identified by electronic medical records. In all, 265 were eligible based on ...
78
EVALUATING HYPOLIPIDEMIC POTENTIAL OF KASNI SEED (CICHORIUM INTYBUS) PREPARATIONS IN NEWLY DIAGNOSED PATIENTS OF METABOLIC DISORDER
... on oral hypoglycemic agent were advised not to take any herbo-mineral preparation during the study duration, and this group served as ...to oral hypoglycemic ...to oral ...
11
Development and validation of a risk prediction model for severe hypoglycemia in adult patients with type 2 diabetes: a nationwide population-based cohort study
... tiple oral hypoglycemic agent use, presence of hypertension or chronic kidney disease, longer duration of diabetes, low or high glucose level, and high Charlson Comorbidity Index score were found to ...
15
Hospice and Palliative Care: A New Movement in India
... Methods: Maternal details were obtained and physical examination was performed on the neonates. Babies were given hourly feeds soon after birth and blood glucoses checked at 1, 3, 5, 9 and 12 hours of life; Hematocrit ...
5
A randomized, double-blind, placebo-controlled trial to assess safety and tolerability during treatment of type 2 diabetes with usual diabetes therapy and either Cycloset™ or placebo
... diet, oral hypoglycemic agents (no more than 2), or insulin (alone or with no more than 1 oral hypoglycemic ...the oral agents or insulin were modified as deemed appropri- ate by the ...
7
Direct in vitro effect of a sulfonylurea to increase human fibroblast insulin receptors
... this oral hypoglycemic agent to increase the number of cell surface insulin receptors or prevent their loss, presumably by slowing the rate of receptor ...
5
“Cost-effectiveness Analysis of Oral Hypoglycemic Drugs for the Treatment of Type-II Diabetes Mellitus in a Tertiary Care Setup Karachi” by Saira Shahnaz, Maqsood Ahmed Khan, Shazia Alam, Tauseef Ahmad, Mudassar Iqbal Arain, Pakistan.
... Majority of patients with type-II diabetes take one or more oral antidiabetic drugs in addition to the first line therapy i.e. Metformin. During the evaluation of prescription record two different treatment ...
6
NEED FOR NEW HYPOGLYCEMIC AGENTS: AN OVERVIEW
... and oral medications. Oral hypoglycemic agents are also useful in the treatment of type 2 ...DM. Oral hypoglycemic agents include sulphonylureas, biguanides, meglitinide, DPP-IV ...
6
Volume 1 | Issue 4 - 2011
... Glipizide (GZ) is a widely used oral hypoglycemic drug with very poor water solubility. The purpose of this study was to enhance the dissolution rate and bioavailability of this drug by developing a novel ...
6
Patients’ perspective of disease and medication adherence for type 2 diabetes in an urban area in Bangladesh: a qualitative study
... on oral hypoglycemic medication based on the prescription by the attending physician, (c) diagnosed with type 2 diabetes for at least one year, and (d) registered with the BIHS ...
8
Evaluation of Antidiabetic Activity of Aqueous Extract of Mangifera Indica Leaves in Alloxan Induced Diabetic Rats
... the hypoglycemic activity of Mangifera ...an oral hypoglycemic drug, gliclazide on alloxan induced diabetic rat ...with oral administration of drugs and the plant extract which was started on ...
7
To Compare the Anti-Inflammatory Effect of Oral Hypoglycemic Drugs in Type 2 Diabetes Mellitus
... Based on this background information, the study targeted the oral hypoglycemic agents like Acarbose and Sitagliptin to look for their anti-inflammatory action.Hence the study aimed to compare the ...
8
Pharmacogenetics in type 2 diabetes: influence on response to oral hypoglycemic agents
... Abstract: Type 2 diabetes is one of the leading causes of morbidity and mortality, consuming a significant proportion of public health spending. Oral hypoglycemic agents (OHAs) are the frontline treatment ...
13
ANTIDIABETIC HERBAL DRUGS: A REVIEW .......
... Clinical study: Agraval, Rai and Singh (1996) in randomized, placebo-controlled, single-bind, crossover trial studied the effects of Ocimum sanctum ( dried leaf 2.5g daily )on fasting and postprandial blood glucose and ...
14
ELICITATION OF TRIGONELLINE, A HYPOGLYCEMIC AGENT IN FENUGREEK SPROUTS BY CALCIUM AND NITRIC OXIDE PRIMING
... Likewise, fenugreek besides having several pharmacological properties it is also reported to possess potent antidiabetic property both in vitro and in vivo system. Fenugreek is known to be a rich source of various ...
6